Evidence map›Paper›PMID 37971311›Full record

ArticleNucleic acids research2023

Structural and biochemical insights into NEIL2's preference for abasic sites.

Brian E Eckenroth, Joshua D Bumgarner, Olivia Matsumoto-Elliott, Sheila S David, Sylvie Doublié

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Research progress on the role of the NEIL family in cancer.Frontiers in cell and developmental biology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brian E EckenrothDepartment of Microbiology and Molecular Genetics, University of Vermont, Stafford Hall, 95 Carrigan Drive, Burlington, VT 05405, USA.ORCID 0000-0003-4818-311X
Joshua D BumgarnerDepartment of Chemistry and Graduate Program in Chemistry and Chemical Biology, University of California Davis, Davis, CA 95616, USA.
Olivia Matsumoto-ElliottDepartment of Chemistry and Graduate Program in Chemistry and Chemical Biology, University of California Davis, Davis, CA 95616, USA.
Sheila S DavidDepartment of Chemistry and Graduate Program in Chemistry and Chemical Biology, University of California Davis, Davis, CA 95616, USA.ORCID 0000-0001-5873-7935
Sylvie DoubliéDepartment of Microbiology and Molecular Genetics, University of Vermont, Stafford Hall, 95 Carrigan Drive, Burlington, VT 05405, USA.ORCID 0000-0002-6294-5304
University of California, Davis · USUniversity of Vermont · US

Funding

User Training & OutreachP30GM138396 · NIGMS · UCHICAGO ARGONNE, LLC · PI ROBERT F. FISCHETTI, JANET L. SMITH · 2020 to 2026
$34.3M
SUBSTRATE SPECIFICITY OF THE BER OXIDATIVE DNA GLYCOSYLASESP01CA098993 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI LEE, ANDREA J · 2004 to 2021
$25.9M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
Structural Investigations Critical to Understanding DNA Damage Recognition and Repair in CancerR50CA233185 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Brian E. Eckenroth · 2018 to 2026
$1.2M
Elucidating Mechanisms of Recognition and Excision of Damaged Bases by NEIL glycosylasesR01GM143557 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAVID, SHEILA SUE · 2021 to 2024
$1.2M
NCI NIH HHS P01 CA098993NCI NIH HHS R50 CA233185NIGMS NIH HHS P30 GM138396NIGMS NIH HHS R01 GM143557NIH HHS P01-CA098993NIH HHS S10 OD012289
6 · The paper itself

Abstract

Cellular DNA is subject to damage from a multitude of sources and repair or bypass of sites of damage utilize an array of context or cell cycle dependent systems. The recognition and removal of oxidatively damaged bases is the task of DNA glycosylases from the base excision repair pathway utilizing two structural families that excise base lesions in a wide range of DNA contexts including duplex, single-stranded and bubble structures arising during transcription. The mammalian NEIL2 glycosylase of the Fpg/Nei family excises lesions from each of these DNA contexts favoring the latter two with a preference for oxidized cytosine products and abasic sites. We have determined the first liganded crystal structure of mammalian NEIL2 in complex with an abasic site analog containing DNA duplex at 2.08 Å resolution. Comparison to the unliganded structure revealed a large interdomain conformational shift upon binding the DNA substrate accompanied by local conformational changes in the C-terminal domain zinc finger and N-terminal domain void-filling loop necessary to position the enzyme on the DNA. The detailed biochemical analysis of NEIL2 with an array of oxidized base lesions indicates a significant preference for its lyase activity likely to be paramount when interpreting the biological consequences of variants.

Indexed as

DNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesOpossumsAnimalsDNADNA DamageDNA RepairHumansMammalsProtein ConformationZinc FingersDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesNEIL2 protein, human

Identifiers

PMID37971311
PMCPMC10711445
OpenAlexW4388722437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.